Latest Fluticasone/salmeterol Stories
The COPD Market Will Fracture with the Continuing Entry of LABA/LAMAs and Other Later-to-Market Bronchodilators, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.
DALLAS, September 19, 2014 /PRNewswire/ -- RnRMarketResearch.com adds asthma drugs market research reports titled "Asthma - Japan Drug Forecast and Market Analysis to 2023",
Clinical Trials Mark Important Milestone in Development of Two Highly Complex Products PITTSBURGH, Sept. 16, 2014 /PRNewswire/ -- Mylan Inc.
OXFORD, England, September 11, 2014 /PRNewswire/ -- Successful Completion of Biomedical Catalyst Programme Prosonix, an innovative speciality
QXFORD, England, September 2, 2014 /PRNewswire/ -- Triggers milestone payment from Mylan Prosonix, an innovative speciality pharmaceutical
While Expressing Concerns about Reimbursement, EU5 Payers Look Favorably on Identifying Anti-IL5 Therapy-Responsive Patients, According to Findings from Decision Resources Group BURLINGTON,
The GlaxoSmithKline settlement involves the District of Columbia and 44 states over the marketing of Advair, Paxil, and Wellbutrin. Port Washington, NY (PRWEB)
LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
LONDON, May 19, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE: GSK) today presented data at the American Thoracic Society (ATS) from a late-stage clinical study.
- In Roman antiquity, the return of a person who had been banished, or taken prisoner by an enemy, to his old condition and former privileges.
- In international law, that right by virtue of which persons and things taken by an enemy in war are restored to their former status when coming again under the power of the nation to which they belonged.